Aldehyde Dehydrogenase 1, a Target of miR‑222, Is Expressed at Elevated Levels in Cervical Cancer

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2020.8425
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Fatty Acid Synthase Is a Primary Target of MiR-15a and MiR-16-1 in Breast Cancer

Oncotarget
Oncology
2016English

MicroRNA-222 (miR-222); miR-181b

Science-Business eXchange
2011English

Overexpression of miR‑221 and miR‑222 in the Cancer Stroma Is Associated With Malignant Potential in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Aldehyde Dehydrogenase 1 Expression Correlates With the Invasion of Breast Cancer

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2015English

Aldehyde Dehydrogenase Activity Is a Cancer Stem Cell Marker of Tongue Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

Reduced Aldehyde Dehydrogenase Expression in Preeclamptic Decidual Mesenchymal Stem/Stromal Cells Is Restored by Aldehyde Dehydrogenase Agonists

Scientific Reports
Multidisciplinary
2017English

ALDH1A1 (Aldehyde Dehydrogenase 1 Family Member A1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2020English

Sodium-Coupled Monocarboxylate Transporter Is a Target of Epigenetic Repression in Cervical Cancer

International Journal of Oncology
Cancer ResearchOncology
2019English

CD44/CD24 and Aldehyde Dehydrogenase 1 in Estrogen Receptor-Positive Early Breast Cancer Treated With Tamoxifen: CD24 Positivity Is a Poor Prognosticator

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy